ED
BSX icon

Exane Derivatives’s Boston Scientific BSX Stock Holding History

Exane Derivatives’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1.6M Sell
43,067
-2,859
-6% -$116K 0.92% 21
2022
Q1 		$2.03M Sell
45,926
-3,459
-7% -$150K 0.57% 33
2021
Q4 		$2.1M Sell
49,385
-47,037
-49% -$1.98M 0.51% 36
2021
Q3 		$4.18M Sell
96,422
-3,695
-4% -$163K 1% 15
2021
Q2 		$4.31M Buy
100,117
+7,755
+8% +$326K 0.98% 18
2021
Q1 		$3.57M Sell
92,362
-16,414
-15% -$621K 1.02% 20
2020
Q4 		$3.91M Buy
108,776
+11,024
+11% +$397K 1.15% 16
2020
Q3 		$3.74M Sell
97,752
-19,354
-17% -$746K 1.08% 22
2020
Q2 		$4.11M Sell
117,106
-1,628
-1% -$58.6K 1.1% 22
2020
Q1 		$3.87M Buy
118,734
+40,954
+53% +$1.6M 1.08% 23
2019
Q4 		$3.31M Buy
77,780
+35,416
+84% +$1.48M 0.61% 58
2019
Q3 		$1.72M Sell
42,364
-1,598
-4% -$67.7K 0.31% 75
2019
Q2 		$1.89M Buy
43,962
+9,479
+27% +$365K 0.33% 72
2019
Q1 		$1.32M Buy
34,483
+33,319
+2,862% +$1.27M 0.26% 89
2018
Q4 		$41.1K Buy
1,164
+1,163
+116,300% +$42.2K 0.01% 373
2018
Q3 		$39 Sell
1
-406
-100% -$14.2K ﹤0.01% 653
2018
Q2 		$13.3K Sell
407
-1,802
-82% -$54.3K ﹤0.01% 449
2018
Q1 		$59K Sell
2,209
-534
-19% -$14.5K 0.01% 341
2017
Q4 		$68.1K Buy
2,743
+2,720
+11,826% +$75K 0.01% 322
2017
Q3 		$671 Sell
23
-127
-85% -$3.51K ﹤0.01% 466
2017
Q2 		$4.16K Sell
150
-1,538
-91% -$40.8K ﹤0.01% 436
2017
Q1 		$42K Sell
1,688
-2,112
-56% -$51.4K 0.01% 277
2016
Q4 		$82.2K Buy
+3,800
New +$82.9K 0.02% 258
2015
Q4 		– Sell
-2,523
Closed -$41.4K – 533
2015
Q3 		$41.4K Buy
+2,523
New +$43.1K 0.01% 286

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Exane Derivatives's BSX Position: Q2 2022 in Review

Exane Derivatives reduced its Boston Scientific (BSX) stake by 6.2% in Q2 2022, selling an estimated $116K and leaving 43,067 shares worth $1.6M. The position accounts for 0.92% of the portfolio, ranked #21.

Exane Derivatives first reported a position in BSX in Q3 2015 and has held it in 24 quarters since. The position peaked at $4.31M in Q2 2021. 879 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

  • Exane Derivatives held 43,067 shares of Boston Scientific worth $1.6M as of Q2 2022.
  • Exane Derivatives sold 2,859 Boston Scientific shares in Q2 2022, an estimated $116K.
  • Boston Scientific made up 0.92% of Exane Derivatives's portfolio in Q2 2022, its #21 holding.
  • Exane Derivatives first reported a position in Boston Scientific in Q3 2015 and has held it in 24 quarters since.
  • Exane Derivatives's Boston Scientific position peaked at $4.31M in Q2 2021.
  • 879 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.